NAALADASE COMPOSITIONS AND METHODS FOR TREATING GLUTAMATE ABNORMALITY AND EFFECTING NEURONAL ACTIVITY IN ANIMALS

摘要

PURPOSE: A method of treating a glutamate abnormality and a method of effecting a neuronal activity in an animal using an NAALADase inhibitor, and a pharmaceutical composition are provided. CONSTITUTION: The pharmaceutical composition comprising: (i) an effective amount of an NAALADase inhibitor for treating a glutamate abnormality or effecting a neuronal activity in an animal; and (ii) a pharmaceutically acceptable carrier. The method of treating a glutamate abnormality in an animal, comprises administering an effective amount of an NAALADase inhibitor to the animal.